We could not find any results for:
Make sure your spelling is correct or try broadening your search.
OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about lif... OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections. The company's product candidates and services combine its Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with its curated MDRO knowledge base. Show more
ROCKVILLE, Md., April 23, 2024 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”) announced today that it received a notice from The Nasdaq Stock Market LLC (“Nasdaq”...
A healthcare company based out of Maryland saw its shares skyrocket on Tuesday after it was announced that David Lazar is going to invest $ million in preferred stock and take To read the full...
David Lazar invests $3 million in Preferred StockNew OpGen Board of Directors appointedDavid Lazar will take over as CEO of OpGenOpGen settles outstanding liabilities with EIB ROCKVILLE, Md...
Total revenue for the first nine months of 2023 was approximately $2.35 million compared to approximately $1.89 million in the first nine months of 2022Implemented certain cash management...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0255 | -3.99498668338 | 0.6383 | 0.6536 | 0.565 | 152145 | 0.62081549 | CS |
4 | -0.3617 | -37.1164699846 | 0.9745 | 0.99 | 0.5582 | 4873950 | 0.73906625 | CS |
12 | 0.2778 | 82.9253731343 | 0.335 | 0.99 | 0.3 | 1821519 | 0.70627746 | CS |
26 | -0.1173 | -16.0662922887 | 0.7301 | 0.99 | 0.24 | 1015901 | 0.67572136 | CS |
52 | -0.3472 | -36.1666666667 | 0.96 | 3.84 | 0.165 | 1717009 | 0.6685082 | CS |
156 | -44.7872 | -98.6502202643 | 45.4 | 74.4 | 0.165 | 1504331 | 14.41631596 | CS |
260 | -10.5032 | -94.4872256207 | 11.116 | 256 | 0.165 | 2127877 | 38.25073852 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions